Diagnostic and Interventional Cardiology DAIC

Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.

Research shows that patients have better outcomes when they are treated at an accredited center, such as the Hypertension Center in the Smidt Heart Institute, by physicians specialized in the disease. Photo by Getty.

News | Hypertension

Smidt Heart Institute’s Hypertension Center Earns Accreditation

July 25, 2023 — The Hypertension Center in the Smidt Heart Institute at Cedars-Sinai has earned accreditation from the A ...

July 25, 2023

A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss Professor in Cardiothoracic Surgery and assistant dean for clinical trials at Weill Cornell Medicine, has been approved for a nearly $30 million funding award from the Patient-Centered Outcomes Research Institute (PCORI).

News | Cardiovascular Clinical Studies

Large PCORI Award Funds Study of Surgical Options for Coronary Artery Disease in Underrepresented Patient Populations

July 25, 2023 — A multi-institutional team of scientists led by Dr. Mario Gaudino, the Stephen and Suzanne Weiss ...

July 25, 2023

With Only 21 Facilities Achieving this Award Nationally, AGH Ranks Among the Most Elite Mitral Valve Programs in the Country and Only Designated Center in Pennsylvania

News | Heart Valve Technology

Allegheny General Hospital Receives Recognition as a Mitral Valve Repair Reference Center from the American Heart Association and the Mitral Foundation

July 24, 2023 — Allegheny General Hospital (AGH), the flagship academic medical center of Allegheny Health Network (AHN) ...

July 24, 2023

BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary disease, announced that the independent Data Safety Monitoring Board (DSMB) has completed its prespecified data review for the ongoing Phase III pivotal CardiAMP Cell Therapy Heart Failure Trial

News | Cardiovascular Clinical Studies

BioCardia Announces DSMB Recommendation to Pause New Enrollment in Phase III Pivotal CardiAMP Cell Therapy Heart Failure Trial While Additional Blinded Data is Collected

July 24, 2023 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

July 24, 2023

Pilot study will assess positive impacts of real-time safety monitoring on patient outcomes and treatment experience

News | Structural Heart

Onecrea Medical Announces the Successful Completion of the First-in-human Implants of its Crea Aortic Valve

July 21, 2023 — Onecrea Medical has announced the success of the first-in-human implants of its Transcatheter Aortic ...

July 21, 2023

The ACC Board of Trustees (BOT) has approved the College's newest officers and trustees who will assume their roles in April 2024 following ACC.24 in Atlanta, Ga.

News | ACC

ACC Announces New 2024 Officers, Trustees

July 20, 2023 — The ACC Board of Trustees (BOT) has approved the College's newest officers and trustees who will assume ...

July 20, 2023

Bicêtre Hospital in Paris, France, and Baptist Stroke & Cerebrovascular Center in Jacksonville, Florida, USA, join global network of leading stroke centers as part of WE-TRUST multicenter clinical trial to evaluate the potential benefits of a Direct to Angio Suite treatment pathway for stroke patients

News | Stroke

First Patients in France and the USA Enrolled in Global WE-TRUST Trial to Accelerate Stroke Diagnosis and Treatment

July 20, 2023 — The first patients in France and the USA have been enrolled into the large-scale WE-TRUST* multicenter ...

July 20, 2023

The future is quite promising for TAHs, but it will be a decade or more before they may become a comparable treatment to heart transplantation

Feature | Artificial Heart | By Francisco Arabia, MD, MBA

Next-Generation Total Artificial Hearts Offer New Hope for Heart Failure Patients

The U.S. organ donation system has long been under scrutiny, with questions about fairness in organ allocation and ...

July 20, 2023

The U.S. Food and Drug Administration (FDA) issued a Letter to Health Care Providers recommending that health care providers, laboratory personnel, and facilities stop using the Quidel Triage Cardiac Panel, manufactured by Quidel Cardiovascular Inc. (QuidelOrtho), and use an alternative method, or an alternate local testing site if available.

News | Heart Failure

FDA Issues Letter to Healthcare Providers on Using Alternative Testing Method for Quidel Triage Cardiac Pane

July 19, 2023 — The U.S. Food and Drug Administration (FDA) is recommending health care providers, laboratory personnel ...

July 19, 2023

EU Physicians have successfully treated the first patients using the combined benefits of Abbott’s Ensite X Mapping System and Stereotaxis’ Robotic Magnetic Navigation System

News | Robotic Systems

Stereotaxis and Abbott Combine Technologies in First Integrated Procedures to Treat Arrhythmia Patients

July 19, 2023 — Stereotaxis, a pioneer and global leader in surgical robotics for minimally invasive endovascular ...

July 19, 2023

Quidel Cardiovascular is recalling its Quidel Triage Cardiac Panels for risk of false negative troponin results that could cause delayed diagnosis or missed myocardial infarction

News | Heart Failure

Quidel Cardiovascular Inc. Recalls Quidel Triage Cardiac Panels for Risk of False Negative Troponin Results

July 18, 2023 — The U.S. Food and Drug Administration (FDA) has issued a Class I recall on Quidel Cardiovascular is ...

July 18, 2023

A new clinical study in Europe examines the applicability and effectiveness of the new TIMELY Platform for telemedical secondary prevention

News | Artificial Intelligence

AI-Supported Telemedicine Platform Aims to Improve the Health of Patients After Myocardial Infarction and Prevent Reinfarctions

July 18, 2023 — The TIMELY consortium announced today the enrollment of the first patient in the randomized controlled ...

July 18, 2023

Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire Versanis, a private clinical-stage biopharmaceutical company focused on the development of new medicines for the treatment of cardiometabolic diseases

News | Cardiovascular Business

Lilly to Acquire Versanis to Improve Patient Outcomes in Cardiometabolic Diseases

July 14, 2023 — Eli Lilly and Company and Versanis Bio today announced a definitive agreement for Lilly to acquire ...

July 14, 2023

Illustration for the deployment and shaping process of the occluder.

News | Structural Heart Occluders

Transcatheter Closure of Perimembranous Ventricular Septal Defect Using a Novel Fully Bioabsorbable Occluder: Multicenter Randomized Controlled Trial

July 14, 2023 — In recent years, transcatheter intervention techniques have emerged as a promising alternative for the ...

July 14, 2023

Feature | Information Technology | By Melinda Taschetta-Millane

One on One ... With Anne Snowdon, RN, PhD, FAAN

Healthcare is constantly evolving, finding new ways to innovate and advance digital tools and technology. With this ...

July 14, 2023